VP, Clinical Development – Solid Tumor Oncology / Immuno-Oncology

Kaye/Bassman is leading a search, partnering with a clinical-stage biotech, to identify a VP, Clinical Development to lead solid tumor program strategy, with immuno-oncology experience a strong plus. This is a hands-on role with direct program ownership — ideal for a physician-leader who wants to stay close to the science rather than a purely oversight seat at a larger organization.
What you’ll own
Clinical strategy and execution across early- and late-stage solid tumor programs, including pivotal Phase 3 planning and regulatory submission support
Direct, hands-on program leadership — this is a build-and-run role, not a delegate-and-review one
Cross-functional collaboration with regulatory, translational, and executive leadership on go/no-go and development-path decisions
Contribution across immuno-oncology mechanisms and solid tumor indications
What you bring
MD (board certification not required)
Industry experience in clinical development with meaningful program ownership
Solid tumor oncology experience; immuno-oncology experience strongly preferred
Experience with pivotal Phase 3 programs and regulatory interactions
Comfort operating in a smaller, agile biotech environment
Breadth across early- and late-stage development preferred